biotechs oversold -quality rebound

  1. bodi69
    214 Posts.
    clock Created with Sketch.
    06/05/05
    14:36
    Post #: 898665
    Better quality biotechs have suffered with the rest.
    Rebounds likely for those with proven technologies, revenues in near future and strong cash positions.
    Well positioned in this category are PTD, NAL, PSD and SPL.
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BC8 Black Cat Syndicate one pour away from being rerated as producer
right-arrow Created with Sketch.
NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.